List of phase III cancer clinical trials 2014

Phase III Clinical Trials by Year

2014 – 2015 – 2016 – 2017

compound	cancer type	reference	companies involved
Imprime	colorectal cancer
Lonsurf (trifluridine and tipiracil hydrochloride)	colorectal cancer		Taiho Pharmaceuticals
Obinutuzumab	chronic lymphocytic leukemia		Roche
Galeterone	prostate cancer		Tokai Pharmaceuticals
momelotinib	myelofibrosis
anastrozole	breast cancer
sapacitabine	acute myeloid leukaemia
everolimus	breast cancer
lenalidomide	blood cancer		Celgene
asparaginase erythrocyte encapsulated	Acute lymphoblastic leukemia
Binimetinib	melanoma
ruxolitinib	pancreatic cancer
rindopepimut	glioblastoma
brentuximab	Hodgkin's lymphoma
crizotinib	non-small-cell lung carcinoma
Multikine	head and neck cancer		CEL-SCI Corporation^[1]
AZD9291	Non-small-cell lung carcinoma	AURA2, AURA3	Astrazeneca
panobinostat	myeloma		Novartis
Algenpantucel-L	pancreatic cancer	IMPRESS	NewLink pharmaceuticals
Livatag	hepatocellular carcinoma		Onxeo
bavituximab	non-small cell lung cancer	SUNRISE trial	Bristol-Myers Squibb
rilotumumab	gastric cancer		Amgen
MPDL3280A	lung cancer and bladder cancer
cidofovir	cervical cancer
leucovorin	pancreatic cancer
rociletinib	Non-small-cell lung carcinoma	TIGER^[2]	Clovis Oncology
DCVax-L	gliobastoma
gefitinib	esophageal cancer
Zoptarelin	endometrial cancer
Ganetespib	lung cancer
nivolumab	melanoma cancer
avastin	ovarian cancer
dacomitinib	Non-small-cell lung carcinoma
ipilimumab	lung cancer
Crizotinib	lung cancer
fosbretabulin	ovarian cancer
Evofosfamide	blood cancer
Tivantinib	lung cancer
afatinib	lung cancer
Daratumumab	multiple myeloma
trastuzumab	breast cancer	Ref
ofatumumab	chronic lymphocytic leukaemia
Eribulin	non-small cell lung cancer	Ref
REOLYSIN	prostate cancer
abraxane	prostate cancer	Ref
enzalutamide	prostate cancer
PV-10	melanoma	Ref
neratinib	breast cancer
Elotuzumab and Nivolumab	blood cancer
ODM-201	prostate cancer	Ref
Olaparib	ovarian cancer	Ref
Folfoxiri	colorectal cancer	Ref
Imbruvica	chronic lymphocytic leukaemia
Nintenadib	mesothelioma
Nintedanib	colorectal cancer	Ref
Xilonix	colorectal cancer
Bevacizumab	ovarian cancer, breast cancer
HA-itrinotecan	metastatic colorectal cancer
Anamorelin	Ref
Palbociclib	breast cancer	Ref
Decapeptyl	prostate cancer
Aprepitant	multiple myeloma
Lenvatinib	hepatocellular carcinoma
Prostvac	prostate cancer	PROSPECT	Bavarian Nordic

References[edit]

↑ Carlson, Bob (2007). "Approvals, FDA Actions, Clinical Trials". Biotechnology Healthcare. 4 (4): 16–22. ISSN 1554-169X. PMC 3541852. PMID 23319929.
↑ "Clinical Trials - CO-1868". National Cancer Institute. U.S. Department of Health and Human Services. Retrieved 14 March 2015.

*Clovis oncology currently being investigated

This article "List of phase III cancer clinical trials 2014" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:List of phase III cancer clinical trials 2014. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

[1] Carlson, Bob (2007). "Approvals, FDA Actions, Clinical Trials". Biotechnology Healthcare. 4 (4): 16–22. ISSN 1554-169X. PMC 3541852. PMID 23319929.

[2] "Clinical Trials - CO-1868". National Cancer Institute. U.S. Department of Health and Human Services. Retrieved 14 March 2015.

[1]

[2]

List of phase III cancer clinical trials 2014

References[edit]

📰 Article(s) of the same category(ies)[edit]